[HTML][HTML] Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review
…, L Nygård, MGM Olde-Rikkert, JM Orgogozo… - Alzheimer's research & …, 2015 - Springer
Introduction There is a growing body of evidence that subtle deficits in instrumental activities
of daily living (IADL) may be present in mild cognitive impairment (MCI). However, it is not …
of daily living (IADL) may be present in mild cognitive impairment (MCI). However, it is not …
Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia
…, DR Royall, RA Bullock, JM Orgogozo… - Journal of the …, 2004 - Elsevier
Vascular cognitive impairment (VCI) was proposed as an umbrella term to include subjects
affected with any degree of cognitive impairment resulting from cerebrovascular disease (…
affected with any degree of cognitive impairment resulting from cerebrovascular disease (…
Vascular dementia: diagnostic criteria for research studies: report of the NINDS‐AIREN International Workshop
…, JC Masdeu, JH Garcia, L Amaducci, JM Orgogozo… - Neurology, 1993 - AAN Enterprises
Criteria for the diagnosis of vascular dementia (VaD) that are reliable, valid, and readily
applicable in a variety of settings are urgently needed for both clinical and research purposes. …
applicable in a variety of settings are urgently needed for both clinical and research purposes. …
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
JM Orgogozo, S Gilman, JF Dartigues, B Laurent… - Neurology, 2003 - AAN Enterprises
Background: AD is characterized by cerebral deposition of β-amyloid plaques with amyloid β-peptide
(Aβ) 42 as the major peptide constituent, along with neurofibrillary tangles and …
(Aβ) 42 as the major peptide constituent, along with neurofibrillary tangles and …
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
…, L Eisner, L Kirby, MB Rovira, F Forette, JM Orgogozo - Neurology, 2005 - AAN Enterprises
Background: AN1792 (beta-amyloid [Aβ]1–42) immunization reduces Aβ plaque burden
and preserves cognitive function in APP transgenic mice. The authors report the results of a …
and preserves cognitive function in APP transgenic mice. The authors report the results of a …
Incidence and outcome of mild cognitive impairment in a population-based prospective cohort
S Larrieu, L Letenneur, JM Orgogozo, C Fabrigoule… - Neurology, 2002 - AAN Enterprises
Objective: To estimate the age-specific incidence rate of mild cognitive impairment (MCI)
according to sex and educational level and to explore the course of MCI, particularly its …
according to sex and educational level and to explore the course of MCI, particularly its …
Prodromal Alzheimer's disease: successive emergence of the clinical symptoms
…, M Le Goff, X Millet, JM Orgogozo… - Annals of Neurology …, 2008 - Wiley Online Library
Objective Whereas cognitive deficits are known to be detectable long before the typical
symptoms of Alzheimer's disease (AD) are evident, previous studies have failed to determine …
symptoms of Alzheimer's disease (AD) are evident, previous studies have failed to determine …
Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300)
JM Orgogozo, AS Rigaud, A Stöffler, HJ Möbius… - Stroke, 2002 - Am Heart Assoc
Background and Purpose— Based on the hypothesis of glutamate-induced neurotoxicity (excitotoxicity)
in cerebral ischemia, this study examined the efficacy and tolerability of …
in cerebral ischemia, this study examined the efficacy and tolerability of …
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area.
JM Orgogozo, JF Dartigues, S Lafont… - Revue …, 1997 - europepmc.org
Alcoholism is a possible cause of dementia, mainly through associated nutritional deficiencies
and, rarely, through acute direct toxicity. However alcohol consumption was not found to …
and, rarely, through acute direct toxicity. However alcohol consumption was not found to …
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?
…, S Gauthier, JC Morris, JM Orgogozo… - … Journal of Geriatric …, 2001 - Wiley Online Library
… , the European Medicine Evaluation Agency EMEA) issued new guidelines for trials of
symptomatic treatments in Alzheimer's disease EMEA, 1997) and vascular dementia Orgogozo …
symptomatic treatments in Alzheimer's disease EMEA, 1997) and vascular dementia Orgogozo …